A citation-based method for searching scientific literature

Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster, David J Lederer, Steven D Nathan, Carlos A Pereira, Steven A Sahn, Robert Sussman, Jeffrey J Swigris, Paul W Noble. N Engl J Med 2014
Times Cited: 1838



John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
Times Cited: 334




List of shared articles



Times cited


Interstitial lung disease and obstructive sleep apnea.
Yet H Khor, Christopher J Ryerson, Shane A Landry, Mark E Howard, Thomas J Churchward, Bradley A Edwards, Garun S Hamilton, Simon A Joosten. Sleep Med Rev 2021
1

Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey).
V Cottin, E Bergot, A Bourdin, H Nunes, G Prévot, B Wallaert, S Marchand-Adam. Respir Med Res 2021
0

PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in Italy.
Carlo Vancheri, Monica Bengus, Laura Bianchino, Maria G Cagnazzo, Alessandra Ghirardini, Donato Lacedonia, Mercedes Pasquali, Gaetano Rea, Sonja A Rohner, Alessandro Sanduzzi,[...]. Pulm Ther 2021
0

Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis.
Victoria A Ptasinski, John Stegmayr, Maria G Belvisi, Darcy E Wagner, Lynne A Murray. Am J Respir Cell Mol Biol 2021
0

Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
Steven L Brody, Sean P Gunsten, Hannah P Luehmann, Debbie H Sultan, Michelle Hoelscher, Gyu Seong Heo, Jiehong Pan, Jeffrey R Koenitzer, Ethan C Lee, Tao Huang,[...]. Am J Respir Crit Care Med 2021
6

Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017.
Niranjan Jeganathan, Rory A Smith, Matheni Sathananthan. Chest 2021
8

Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis.
Enrica Di Martino, Alessio Provenzani, Patrizio Vitulo, Piera Polidori. Ann Pharmacother 2021
2